As per Fact.MR, a market research and competitive intelligence provider, the hyperbaric oxygen therapy (HBOT) devices market was valued at US$ 4.02 Bn in 2021.
At 1.5 to 3 times the average atmospheric pressure, hyperbaric oxygen therapy devices supply 100% pure oxygen to the bodily tissues. Excess oxygen in the circulation encourages the production of white blood cells and leucocytes, which fight bacteria, as well as the secretion of stem cells, which aids in speedier healing and the restoration of normal body function.
Hyperbaric oxygen therapy devices are used to treat chronic problem wounds by delivering oxygen to all body tissues through monoplace HBOT chambers, multiplace HBOT chambers or topical HBOT chambers.
For critical insights on this market, request for More Info – https://www.factmr.com/connectus/sample?flag=S&rep_id=7258
Key Segments Covered in Hyperbaric Oxygen Therapy Devices Industry Research
-
Hyperbaric Oxygen Therapy Devices Market by Product:
- Monoplace HBOT Devices
- Multiplace HBOT Devices
-
Hyperbaric Oxygen Therapy Devices Market by Application:
- Wound Healing
- Decompression Sickness
- Infection Treatment
- Gas Embolism
-
Hyperbaric Oxygen Therapy Devices Market by Region:
- North America Hyperbaric Oxygen Therapy Devices Market
- Europe Hyperbaric Oxygen Therapy Devices Market
- Asia Pacific Hyperbaric Oxygen Therapy Devices Market
- Latin America Hyperbaric Oxygen Therapy Devices Market
- Middle East & Africa Hyperbaric Oxygen Therapy Devices Market
Request more information about Report Methodology – https://www.factmr.com/connectus/sample?flag=RM&rep_id=7258
Competitive Landscape
Rising investments by key players in R&D and the development of hyperbaric oxygen therapy products will be vital to preserving a competitive edge, with regular alliances being formed in an attempt to diversify product portfolios and increase market share.
For instance,
- In November 2019, AHA Hyperbarics introduced the AHA Flex V2, a new model of innovative high-pressure medical hyperbaric chambers that are specifically built to meet the growing need for HBOT safety and efficacy.
COVID-19 Impact on Sales of Hyperbaric Oxygen Therapy Products
The COVID-19 pandemic significantly impacted the healthcare industry. The use of hyperbaric oxygen therapy devices as an alternate treatment for COVID-19-related hypoxia has grown in favor. Rising acceptance as an emergency investigative device supported the industry growth during the pandemic.
Increasing government and private studies demonstrating hyperbaric oxygen therapy’s high effectiveness in improving survival rates will boost market demand over the coming years.
For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/7258
Hyperbaric oxygen therapy devices are becoming more common in the healthcare system as the prevalence of wound site infection rises. Rapid healing necessitates an abundance of oxygen. Hyperbaric oxygen therapy involves exposing the body to 100% oxygen in the injured area in order to speed up the healing process.
Because of the rising occurrences of obesity and diabetes around the world, demand for hyperbaric oxygen therapy systems in wound healing applications will rise. Segment growth will be fueled by factors such as rising healthcare expenses and an ageing population. One of the few aspects that can be attributed to the greatest market share is the availability of improved solutions for the treatment of chronic wounds.
For More Insight- https://www.factmr.com/article/124/latest-trends-in-the-healthcare-industry-how-has-it-transformed-businesses
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
